erwinia asparaginase
Sponsor DAN · listed as DAN
READOUT
Phase 2;Phase 3
Confidence: medium
Source: clinicaltrials
Next catalyst
Event typeREADOUT
Expected date2026-09-30
As disclosedSep 30, 2026
Date precisionday
Confidencemedium
Trial & sponsor
Trial (NCT)NCT03117751
PhasePHASE2;PHASE3
StatusACTIVE_NOT_RECRUITING
Lead sponsorSt. Jude Children's Research Hospital
Listed asDAN
Condition(s)Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma
All tracked catalysts for erwinia asparaginase
| Date | Event | Confidence | Trial |
|---|---|---|---|
| 2026-09-30 | READOUT | medium | NCT03117751 |
| 2026-11-30 | READOUT | medium | NCT03020030 |
!
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.
Get the full dataset — $499 → More DAN catalysts